Association studies between the HSD11B2 gene (encoding human 11β-hydroxysteroid dehydrogenase type 2), type 1 diabetes mellitus and diabetic nephropathy

European Journal of Endocrinology

Volumn 146, Issue 4, 2002, Pages 553-558

  Lavery, Gareth G ^a   McTernan, Claire L ^a   Bain, Stephen C ^a   Chowdhury, Tahseen A ^a   Hewison, Martin ^a   Stewart, Paul M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ADENINE; CYTOSINE; HYDROCORTISONE; MINERALOCORTICOID; SODIUM CHLORIDE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE DURATION; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INTRON; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; NUCLEOTIDE REPEAT; PHENOTYPE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

EID: 0036230494     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1460553     Document Type: Article

References (35)

1. Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor
2. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle
3. Hypertension in the syndrome of apparent mineralo-corticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene
4. 11Beta-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess
5. 11Beta-hydroxysteroid dehydrogenase
6. Reduced 11beta-hydroxysteroid dehydrogenase activity in patients with the nephrotic syndrome
7. Mineralocorticoid hypertension and congenital deficiency of 11beta-hydroxysteroid dehydrogenase in a family with the syndrome of 'apparent' mineralocorticoid excess
8. Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2
9. The United States Renal Data System's 1991 annual data report: An introduction
10. Genetic determinants of diabetic nephropathy
11. Examination of two genetic polymorphisms within the renin-angiotensin system: No evidence for an association with nephropathy in IDDM
12. Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin-dependent diabetes mellitus
13. Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy
14. Central role of sodium in hypertension in diabetic subjects
15. Pathogenesis, prevention, and treatment of diabetic nephropathy
16. Increased prevalence of salt sensitivity of blood pressure in IDDM with and without microalbuminuria
17. CA-repeat polymorphism in intron 1 of HSD11B2: Effects on gene expression and salt sensitivity
18. Molecular basis of human salt sensitivity: The role of the 11beta-hydroxysteroid dehydrogenase type 2
19. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by diuretics and the renin-angiotensin-aldosterone axis
20. Renal 11beta-hydroxysteroid dehydrogenase activity is enhanced by ramipril and captopril
21. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: An epidemiological study
22. Is diabetic nephropathy an inherited complication?
23. Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs
24. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy
25. Deficient inactivation of cortisol by 11beta-hydroxysteroid dehydrogenase in essential hypertension
26. Structural analysis and evaluation of the 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) gene in human essential hypertension
27. Genetic association of 11beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) flanking microsatellites with essential hypertension in blacks
28. Salt sensitivity of blood pressure in humans
29. Salt sensitivity in hypertensive type-1 diabetes mellitus
30. Microalbuminuria is associated with salt sensitivity in hypertensive patients
31. Cloning and tissue distribution of the human 11beta-hydroxysteroid dehydrogenase type 2 enzyme
32. Type 1 11beta-hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets
33. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure
34. Gene expression of 11beta-hydroxysteroid dehydrogenase type 1 and type 2 in the kidneys of insulin-dependent diabetic rats
35. Effects of spironolactone on systolic blood pressure in experimental diabetic rats